Poor outcome in end-stage heart failure patients with low circulating calcitriol levels

European Journal of Heart Failure

Volumn 10, Issue 3, 2008, Pages 321-327

  Zittermann, Armin ^a   Schleithoff, Stefanie S ^a   Götting, Christian ^b   Dronow, Oxana ^a   Fuchs, Uwe ^a   Kuhn, Joachim ^b   Kleesiek, Knut ^b   Tenderich, Gero ^a   Koerfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Calcitriol; Cytokines; Heart failure; Survival; Vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

EID: 40249100100     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.01.013     Document Type: Article

References (32)

1. Swedberg K. Cleland J. Dargie H. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 2005 26 1115 1140
2. Jessup M. Brozena S. Heart failure N Engl J Med 2003 348 2007 2018
3. Zittermann A. Schleithoff S.S. Tenderich G. Berthold H.K. Körfer R. Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003 41 105 112
4. Li Y.C. Kong J. WEi M. Chen Z.F. Liu S.Q. Cao L.P. 1,25‐Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin‐angiotensin system J Clin Invest 2002 110 229 238
5. Xiang W. Kong J. Chen S. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac rennin‐angiotensin systems Am J Physiol Endocrinol Metabol 2005 288 E125 E132
6. Simpson R.U. Hershey S.H. Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse J Steroid Biochem Mol Biol 2007 103 521 524
7. Goodwin K.D. Ahokas R.A. Bhattacharya S.K. Sun Y. Gerling I.C. Weber K.T. Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements Am J Med Sci 2006 332 73 78
8. Beuckelmann D.J. Näbauer M. Erdmann E. Intercellular calcium handling in isolated ventricular myocardium Circulation 1992 85 1046 1055
9. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease Prog Biophys Mol Biol 2006 92 39 48
10. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation Kidney Int 2006 69 33 43
11. Haug C.J. Aukrust P. Haug E. Morkrid L. Muller F. Froland S.S. Severe deficiency of 1,25‐dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis J Clin Endocrinol Metab 1998 83 3832 3838
12. Zittermann A. Schleithoff S.S. Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 2006 11 25 33
13. Califf R.M. Adams K.F. McKenna W.J. A randomised controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomised Survival Trial (FIRST) Am Heart J 1997 134 44 54
14. Visser M. Deeg D.J.H. Puts M.T.E. Seidell J.C. Lips P. Low serum concentrations of 25‐hydroxyvitamin D in older persons and the risk of nursing home admission Am J Clin Nutr 2006 84 616 622
15. Roodnat J.I. Mulder P.G.H. Tielens E.T. van Riemsdiek I.C. van Gelder T. Weimar W. The Cox proportional hazards analysis in words: examples in the renal transplantation field Transplantation 2004 77 483 488
16. Park C.W. Oh Y.S. Shin Y.S. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism Am J Kidney Dis 1999 33 73 81
17. Hochhauser E. Barak J. Kushnir T. Mechanical, biochemical, and structural effects of vitamin D deficiency on the chick heart Angiology 1989 40 300 308
18. Spinale F.G. Matric metalloproteinases: regulation and dysregulation in the failing heart Circ Res 2002 90 520 530
19. Heymans S. Schroen B. Vermeersch P. Increased cardiac expression of tissue inhibitor of metalloproteinase‐1 and tissue inhibitor of metalloproteinase‐2 is related to cardiac fibrosis and dysfunction in the chronic pressure‐overloaded human heart Circulation 2005 112 1136 1144
20. Timms P.M. Mannan N. Hitman G.A. Circulating MMP9, vitamin D and variation in the TIMP‐1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002 95 787 796
21. Teng M. Wolf M. Ofsthuin M.N. Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol 2005 16 1115 1125
22. Shoji T. Shinohara K. Kimoto E. Lower risk for cardiovascular mortality in oral 1aplha‐hydroxy vitamin D3 users in a hemodialysis population Nephrol Dial Transplant 2004 19 179 184
23. Holick M.F. Vitamin D: the underappreciated D‐lightful hormone that is important for skeletal and cellular health Curr Opin Endocrinol Diabetes 2002 9 87 98
24. Autier P. Gandini S. Vitamin D supplementation and total mortality Arch Int Med 2007 167 1730 1737
25. Deswal A. Petersen N.J. Felman A.M. Young J.B. White B.G. Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 2001 103 2055 2059
26. Ananad I.S. Latini R. Florea V.G. C‐reactive protein in heart failure: prognostic value and the effect of valsartan Circulation 2005 112 1428 1434
27. Muller K. Haahr P.M. Diamant M. Rieneck K. Kharazmi A. Bendtzen K. 1,25‐dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post‐transcriptional level Cytokine 1992 4 506 512
28. Schleithoff S.S. Zittermann A. Tenderich G. Berthold H.K. Stehle P. Koerfer R. Vitamin D supplementation improves cytokine profile in patients with congestive heart failure: a double‐blind, randomized, placebo‐controlled trial Am J Clin Nutr 2006 83 754 759
29. Van den Berge G. Van Roosbroeck D. Vanhove P. Wouters P.J. DePourcq L. Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D J Clin Endocrinol Metab 2003 88 4623 4632
30. Haug C.J. Aukrist P. Haug E. Markrid L. Müller F. Froland S.S. Severe deficiency of 1,25‐dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis J Clin Endocrinol Metab 1998 83 3832 3838
31. Ogino K. Burkhoff D. Bilezikian J.P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH‐related protein Endocrinology 1995 136 3024 3030
32. Hartmann F. Packer M. Coats A.J. NT‐proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT‐proBNP substudy Eur J Heart Fail 2004 6 343 350